Covid 19 vaccine: Pfizer, Johnson & Johnson vaccine rollout in India could take a few months | India News


MUMBAI: US pharma giants Pfizer, Johnson & Johnson, and Novavax could be among the potential gainers from the government’s decision on Tuesday to fast-track approvals for foreign-produced Covid-19 vaccines authorised by major global regulators.

While J&J is keen to enter India and has recently held preliminary discussions to apply for emergency use authorisation, Pfizer withdrew from the race in February due to regulatory issues.

Govt fast-tracks nod for Covid vaccination cleared in other countries

- Advertisement -

With surging Covid-19 cases fuelling calls for faster vaccination, the Centre on Tuesday enabled faster access to foreign-made vaccines by doing away with bridging trial studies prior to the grant of emergency authorisation for shots approved by recognised regulators like the US FDA or UK’s MHRA. The changes are intended to increase the availability of jabs amid the second wave.

The rollout of vaccines from Pfizer and J&J could take a few months as the companies are yet to decide their strategies, sources told TOI, adding Pfizer could face issues due to limited manufacturing capacity. At present, vaccinations are on full throttle in the US and Pfizer has already committed its supply to exports and to GAVI, the Vaccine Alliance, a UN initiative.

- Advertisement -


The US has administered nearly 100 million doses of the Pfizer vaccine till now, according to the Centers for Disease Control and Prevention. The company will deliver 200 million doses by May-end and reach 300 million by July. Brazil, Colombia, Mexico, the Philippines, South Africa and Ukraine are set to be among the main recipients of the Pfizer vaccine between April and June, according to GAVI.

Follow live updates on Covid-19 outbreak

“We have noted the recent announcement with regard to the regulatory pathway for global vaccines. We remain committed to continuing our engagement with the government towards making the Pfizer and BioNTech vaccine available for use in the government’s immunisation program in the country,” a Pfizer spokesperson said.

- Advertisement -

Experts say Pfizer could have first-mover advantage since it was the first to apply for emergency authorisation last year, in December, but provided it has enough doses for India. The company had withdrawn in February after the government had decided against recommending it in the absence of data from local clinical trials.

It is understood that the government’s decision on Tuesday came as a big surprise; both companies have said they would take a few days to firm up plans.

Covid-19: Centre in talks with industry for oxygen supply

The Centre is in talks with industry, especially steel plants and oil refineries, to step up supply of oxygen for meeting the requirements of Covid-19 patients. While the government has been tapping into surplus oxygen available with these sectors, over the last two-three days efforts have been initiated to get more supplies without affecting production.

In the case of J&J, the US drugs major initiated talks with the Centre recently to start a bridging clinical study of the Janssen Covid-19 vaccine, but it now may get a leg up from the government’s decision on Tuesday. J&J had announced a tie-up with Hyderabad-based Biological E in August last year.

India, with the largest manufacturing capacity of vaccines globally, is, ironically, facing a major shortage of vaccines, with several states facing delays and running out of stock over the last few days. It has administered over 10 crore doses till now but needs to ramp up due to surging Covid-19 cases.

Also, trials of a vaccine by another US company, Novavax, started in India in March, with the aim of launching by September. Tuesday’s government decision could also fast-track this vaccine.

Meanwhile, the mRNA vaccine from US firm Moderna will be months away, with the company still in early talks with the Council of Scientific and Industrial Research for a possible tie-up, according to news reports.


Source Link

- Advertisement -

Share

Latest Updates

FCC Fines Sinclair Affiliated Stations $9M For Breach Of Good Faith – Deadline

The FCC Wednesday announced fines totaling $9 million on 17 stations – or eight licensees – affiliated with Sinclair Broadcast Group for not negotiating...

NXIVM’s Lauren Salzman Evades Prison Time For Role In Cult – Deadline

Former high-ranking NXIVM member Lauren Salzman has avoided prison time for her role in the cult. She was sentenced on Wednesday to time served,...

Informercial Pioneer, Pocket Fisherman Seller Was 86 – Deadline

Ron Popeil, the Ronco founder who all but created the late-night infomercial and pitched such durable — in memory if not quality —...

Trending News

FCC Fines Sinclair Affiliated Stations $9M For Breach Of Good Faith – Deadline

The FCC Wednesday announced fines totaling $9 million on 17 stations – or eight licensees – affiliated with Sinclair Broadcast Group for not negotiating...

NXIVM’s Lauren Salzman Evades Prison Time For Role In Cult – Deadline

Former high-ranking NXIVM member Lauren Salzman has avoided prison time for her role in the cult. She was sentenced on Wednesday to time served,...

Informercial Pioneer, Pocket Fisherman Seller Was 86 – Deadline

Ron Popeil, the Ronco founder who all but created the late-night infomercial and pitched such durable — in memory if not quality —...

NBC’s Olympics Coverage Shines Amid Reruns, Marks Peacock’s Most-Consumed Tuesday – Deadline

Coverage of the 2020 Tokyo Olympics on NBC stabilized Tuesday evening airing to 14.9 million viewers and earning a 3.5 rating in the...

Big 12 Hits At ESPN Over Texas, Oklahoma Bid For SEC Move – Deadline

The Big 12’s commissioner is accusing ESPN of trying to “destabilize” his league by “incentivizing” other NCAA conferences in an effort to get...

Vaccinations Alone Will Not End Sydney’s COVID-19 Lockdown: Scott Morrison

<!-- -->A total of 177 cases were detected, most of them in state capital Sydney on Wednesday (File)Sydney: Australian Prime Minister Scott Morrison...